Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
Provided By GlobeNewswire
Last update: Jun 12, 2025
PITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models exclusively for Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services.
Read more at globenewswire.com
